Published 2019-07-02
Maria Christina Shanty Sherly Yuniarchan Mia Ratwita Andarsini I Dewa Gede Ugrasena Bambang Permono Risky Vitria Prasetyo


Objective: Wilms’ tumor is the most common childhood renal tumor for about 6% of pediatric malignant disease. The 5-year survival rate in United States increased from approximately from 70% (1970-1973) to 92% (1989-1996). This study was aim to analyze the risk factors of mortality in children with Wilms’ tumor. Material & Methods: A cross-sectional study was conducted in children with Wilms’ tumor at Soetomo Hospital during 2006-2011. The data of demographic, clinical profile, complete blood count, blood urea nitrogen, glomerular filtration rate, histological type, disease stage, metastases and relapse were analyzed as risk factors of mortality using logistic regression. Results: There were 37 Wilms’ tumor children and 5 children were excluded because of incomplete data. The mean age was 3.0 (SD 2.6) years, and male-to-female ratio was 2.5 : 1. There were 5/32 children in stage I, 7/32 children in stage II, 8/32 children in stage III, 11/32 children in stage IV, and 1/32 children in stage V. There were 15/32 children underwent operation. Complete remission occurred in 12/32 children and 1/32 children relapsed. There were 20/32 children died, associated with anemia (P=0.033, OR=6.111, 95% CI=1.056-35.352) and advanced stage (P=0.021, OR=8.000, 95% CI=1.575-40.632). The risk of mortality increased 3.284 folds with every increased stage (P=0.007, 95% CI=1.338-7.775). Conclusion: Disease stage is the significant risk factor of mortality in children with Wilms’ tumor.  



Wilms’ tumor, risk factor, mortality, children


Faranous M, Bahoush GR, Mehrvar A, Hejazi S, Vossough P, Hedayatiasl A, etc. Wilm’s tumor: epidemiology and survival. Res J Biol Sci. 2009; 4: 86-9.

Haddadin I, Hazza I. Wilms’ tumor experience at King Hussein Medical Center. Saudi J Kidney Dis Transplant. 2000; 11: 35-9.

Davidoff AM. Wilms’ tumor. Curr Opin Pediatr. 2009; 21: 357-64.

Cotton CA, Peterson S, Norkoo PA, Takashima J, Grigoriev Y. Breslow NE. Early and late mortality after diagnosis of Wilms’ tumor. J Clin Oncol. 2009; 27: 1304-9.

Stefanowicz J, Kosiak M, Romanowicz G, Owczuk R, Drożyńska EA, Balcerska A. Glomerular filtration rate and prevalence of chronic kidney disease in Wilms’ tumour survivors. Pediatr Nephrol. 2011; 26: 759–66.

Ko EY, Ritchey ML. Current management of Wilms’ tumor in children. Journal of Pediatric Urology. 2009; 5: 56-65.

Gupta DK, Sharma S, Agarwala S, Carachi R. Saga of Wilms’ tumor: lessons learnt from the past. J Indian Assoc Pediatr Surg. 2005; 10: 217-29.

Shamberger RC, Guthne KA, Ritchey ML, Haase GM, Takashima J, Beckwith JB, et al. Surgery-related factors and local recurrence of Wilms’ tumor in National Wilms tumor study 4. Ann Surg. 1999; 229: 292-97.

Biswas S, Bose K, Mukhopadhyay A, Bhadra M. Mid-upper arm circumference based undernutrition among Bengalee children of Chapra, West Bengal, India. Iran J Pediatr. 2010; 20: 63-8.

Israel T, Borgstein E, Jamali M, Kraker J, Caron HN, Molyneux EM. Acute malnutrition is common in Malawian patient with a Wilms tumour; a role for “peanut butter”? Download from http://dare.uva.nl/document/173502. Access at 23/8/2012.

Chung DH. Pediatric solid malignancies: neuroblastoma and Wilms’ tumor. Surg Clin. 2006; 86: 24-42.

Bhatnagar S. Management of Wilms’ tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg. 2009; 14: 6-15.

Wright KD, Green DM, Daw NC. Late effects of treatment for Wilms’ tumor. Pediatr Hematol Oncol. 2009; 26: 407-13.

Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University